Equities

Corcept Therapeutics Inc

Corcept Therapeutics Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)57.79
  • Today's Change-1.27 / -2.15%
  • Shares traded1.17m
  • 1 Year change+130.88%
  • Beta0.5160
Data delayed at least 15 minutes, as of Nov 12 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue482402366
OPERATING EXPENSES
Cost of revenue total6.485.395.28
Selling, general and admin. expenses, total184153122
Depreciation/amortization------
Unusual expense(income)00--
Other operating expenses, total------
Total operating expense375289242
Operating income107113124
Other, net------
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes125116125
Provision for income taxes181512
Net income after taxes106101113
Minority interest------
Net income before extra. Items106101113
Total extraordinary items------
Net income106101113
Inc.avail. to common excl. extra. Items106101113
Inc.avail. to common incl. extra. Items106101113
EPS RECONCILIATION
Basic/primary weighted average shares104107116
Basic/primary eps excl. extra items1.020.950.97
Basic/primary eps incl. extra items1.020.950.97
Dilution adjustment------
Diluted weighted average shares112116126
Diluted eps excl. extra items0.950.870.89
Diluted eps incl. extra items0.950.870.89
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental------
SUPPLEMENTAL INCOME
Depreciation, supplemental0.580.781.07
Total special items00--
NORMALISED INCOME
Normalized income before taxes125116125
Effect of special items on income taxes00--
Income tax excluding impact of special items181512
Normalized income after tax106101113
Normalized income avail. to common106101113
Basic normalized EPS1.020.950.97
Diluted normalized EPS0.950.870.89
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.